SXCI Related Analyst Ratings
-
JMP Resumes PBM Providers: CVS, MCK, ESRX at Outperform, CTRX at Market Perform
-
Barclays Reinstated SXC Health Solutions (SXCI) at Overweight
-
Goldman Sachs Resumes Coverage on SXC Health Solutions (SXCI) at Buy; Strong Growth Beyond Integration
-
TD Securities Raises Price Target on SXC Health Solutions (SXCI); Getting VIP Card to PBM Industry
-
JPMorgan Resumes SXC Health Solutions (SXCI) at Overweight
-
Jefferies Maintains a 'Buy' on SXC Health Solutions (SXCI); New Compelling Large Cap Growth Story
-
CIBC Starts SXC Health Solutions (SXCI) at Sector Perform
-
Credit Suisse Upgrades SXC Health Solutions (SXCI) to Outperform
-
UBS on Healthcare Distribution - PBMs: Implications from SXCI/CHSI Deal
-
Jefferies Positive On SXC Health Solutions (SXCK) Takeover, Lifts Price Target
-
BMO Capital Downgrades SXC Health Solutions (SXCI) to Market Perform
-
Goldman Sachs Upgrades SXC Health Solutions (SXCI) to Buy, Sees 19% Upside
-
Jefferies Raises Estimates/PT onSXC Health (SXCI) After Q4 Results; Stock Has Strong Legs
-
Jefferies Lifts Numbers on SXC Health Solutions (SXCI) After BCBS-RI Contract Win
-
Morgan Stanley Downgrades SXC Health Solutions (SXCI) to Equalweight
-
Jefferies Raises Price Target on SXC Health Solutions (SXCI), Looks to Top Long & Short Term Outlook
-
Goldman Sachs Starts SXC Health Solutions (SXCI) at Neutral
-
Cowen Upgrades SXC Health Solutions (SXCI) to Outperform
-
GMP Securities Upgrades SXC Health Solutions (SXCI) to Buy
-
UBS Maintains a 'Neutral' on SXC Health Solutions (SXCI); Mgmt Believes All Cylinders in Place Thru 2015
-
Jefferies Comments on Impact of CIGNA's (CI) Pending HealthSpring (HS) Acquisition on SCX (SXCI)
-
BMO Capital Upgrades SXC Health Solutions (SXCI) to Outperform
-
Oppenheimer Starts SXC Health Solutions (SXCI) at Perform
-
TD Newcrest Starts SXC Health Solutions (SXCI) at Buy; New Business Momentum Bodes Well
-
Morgan Stanley Starts SXC Health Solutions (SXCI) at Overweight
-
Dougherty & Co Upgrades SXC Health Solutions (SXCI) to Buy; Stock Price Correction Opens The Door For Solid Appreciation
-
FBR Capital Starts SXC Health Solutions (SXCI) at Outperform; HIT and PBM: A Match Made in Heaven
-
Cowen Starts Healthcare Stocks: ESRX, MHS, MDRX, CAH, MCK, ABC at Outperform, CERN, SXCI, QSII at Neutral
-
Jefferies Starts SXC Health Solutions (SXCI) at Buy
-
BB&T Capital Starts SXC Health Solutions (SXCI) at Buy
-
Paradigm Downgrades SXC Health Solutions (SXCI) to Hold
-
GMP Securities Downgrades SXC Health Solutions (SXCI) to Hold, Price Target $58.65
-
UBS on U.S. Healthcare Distribution: 2011 Outlook and Quarterly Preview
-
Citi Starts SXC Health Solutions (SXCI) at Buy
-
Citi Starts SXC Health Solutions (SXCI) at Buy
-
Maxim Group Starts SXC Health Solutions (SXCI) at Buy
-
Credit Suisse Starts SXC Health Solutions (SXCI) at Neutral
-
UBS Maintains a 'Neutral' on SXC Health Solutions (SXCI); The Story Just Keeps Getting Better
-
Paradigm Downgrades SXC Health Solutions (SXCI) to Hold
-
Stifel Nicolaus Downgrades SXC Health Solutions (SXCI) to Hold
-
Paradigm Research Downgrades SXC Health Solutions (SXCI) to Hold
-
Leerink Swann Initiates Coverage on SXC Health Solutions (SXCI) with an Outperform
-
Before The Open: Barclays Initiated Coverage on SXC Health Solutions (SXCI)
-
UBS Maintains a 'Neutral' on SXC Health Solutions (SXCI); Shifting Greater Focus on 2011 - Raises PT
-
UBS Reiterates a 'Neutral' Rating on SXC Health Solutions (SXCI); Raises PT
-
ThinkEquity Upgrades SXC Health Solutions (SXCI) to Buy
-
JMP Securities Upgrades SXC Health Solutions (SXCI) to Market Outperform
-
BMO Capital Initiates Coverage on SXC Health Solutions (SXCI) with a Market Perform
-
UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
-
SXC Health Solutions (SXCI) Sinks Amid Thomas Weisel Intraday Downgrade
Back to SXCI Stock Lookup
